These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19522714)

  • 1. A survey of vitiligo management among dermatologists in Saudi Arabia.
    AlGhamdi KM
    J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1282-8. PubMed ID: 19522714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of vitiligo patients and attitude of dermatologists towards vitiligo.
    Ongenae K; Van Geel N; De Schepper S; Vander Haeghen Y; Naeyaert JM
    Eur J Dermatol; 2004; 14(3):177-81. PubMed ID: 15246945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of vitiligo. Results of a questionnaire among dermatologists in The Netherlands.
    Njoo MD; Bossuyt PM; Westerhof W
    Int J Dermatol; 1999 Nov; 38(11):866-72. PubMed ID: 10583624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
    Parsad D; Kanwar AJ; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitiligo management strategy in Jeddah, Saudi Arabia as reported by dermatologists and experienced by patients.
    Ismail SA; Sayed DS; Abdelghani LN
    J Dermatolog Treat; 2014 Jun; 25(3):205-11. PubMed ID: 23273274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of dermatologists' phototherapy practices for vitiligo.
    Alghamdi KM; Khurram H; Taïeb A
    Indian J Dermatol Venereol Leprol; 2012; 78(1):74-81. PubMed ID: 22199064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
    Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z
    J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
    Westerhof W; Nieuweboer-Krobotova L
    Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of quality of life in Saudi patients with vitiligo in a medical school in Qassim province, Saudi Arabia.
    Al Robaee AA
    Saudi Med J; 2007 Sep; 28(9):1414-7. PubMed ID: 17768471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcipotriene and corticosteroid combination therapy for vitiligo.
    Travis LB; Silverberg NB
    Pediatr Dermatol; 2004; 21(4):495-8. PubMed ID: 15283800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and prescribed treatments in childhood psoriasis: a survey among medical professionals.
    De Jager ME; Van de Kerkhof PC; De Jong EM; Seyger MM
    J Dermatolog Treat; 2009; 20(5):254-8. PubMed ID: 19418330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of tacrolimus ointment in vitiligo alone or in combination therapy.
    Berti S; Buggiani G; Lotti T
    Skin Therapy Lett; 2009 May; 14(4):5-7. PubMed ID: 19585060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vitiligo--loss of cutaneous pigmentation].
    Sitek JC
    Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2370-2. PubMed ID: 16998548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of vitiligo to PUVA therapy in Saudi patients.
    Tallab T; Joharji H; Bahamdan K; Karkashan E; Mourad M; Ibrahim K
    Int J Dermatol; 2005 Jul; 44(7):556-8. PubMed ID: 15985023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
    Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area.
    Welsh O; Herz-Ruelas ME; Gómez M; Ocampo-Candiani J
    Int J Dermatol; 2009 May; 48(5):529-34. PubMed ID: 19416388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The practice guideline 'vitiligo'].
    Menke HE; van Everdingen JJ
    Ned Tijdschr Geneeskd; 2006 Sep; 150(36):1976-81. PubMed ID: 17002186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of severe psoriasis. A national survey.
    Peckham PE; Weinstein GD; McCullough JL
    Arch Dermatol; 1987 Oct; 123(10):1303-7. PubMed ID: 3662561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on skin repigmentation therapies in vitiligo.
    Falabella R; Barona MI
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):42-65. PubMed ID: 19040503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.